Global Contract Pharmaceutical Manufacturing Market Growth (Status and Outlook) 2024-2030
Contract Pharmaceutical Manufacturing market grows from US$85.45 billion in 2023 to US$129.51 billion by 2030, with a 6.1% CAGR, driven by increasing demand.
According to our publisher’s latest study, the global Contract Pharmaceutical Manufacturing market size was valued at US$ 85450 million in 2023. With growing demand in downstream market, the Contract Pharmaceutical Manufacturing is forecast to a readjusted size of US$ 129510 million by 2030 with a CAGR of 6.1% during review period.
The research report highlights the growth potential of the global Contract Pharmaceutical Manufacturing market. Contract Pharmaceutical Manufacturing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Contract Pharmaceutical Manufacturing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Contract Pharmaceutical Manufacturing market.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.
North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.
In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.
Key Features:
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Manmayi Raval
Research Consultant
The report on Contract Pharmaceutical Manufacturing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Contract Pharmaceutical Manufacturing market. It may include historical data, market segmentation by Type (e.g., Oral, Injectable), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Contract Pharmaceutical Manufacturing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
Competitive Landscape: The research report provides analysis of the competitive landscape within the Contract Pharmaceutical Manufacturing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Contract Pharmaceutical Manufacturing industry. This include advancements in Contract Pharmaceutical Manufacturing technology, Contract Pharmaceutical Manufacturing new entrants, Contract Pharmaceutical Manufacturing new investment, and other innovations that are shaping the future of Contract Pharmaceutical Manufacturing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Contract Pharmaceutical Manufacturing market. It includes factors influencing customer ' purchasing decisions, preferences for Contract Pharmaceutical Manufacturing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Contract Pharmaceutical Manufacturing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Contract Pharmaceutical Manufacturing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Contract Pharmaceutical Manufacturing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Contract Pharmaceutical Manufacturing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Contract Pharmaceutical Manufacturing market.
Market Segmentation:
Contract Pharmaceutical Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Contract Pharmaceutical Manufacturing Market Segmentation
The Contract Pharmaceutical Manufacturing (CMO) market is segmented by two key factors: Type and Application. This segmentation helps understand market trends, product development, and target audiences. Here's a breakdown of each segment:
Segmentation by Type:
• Oral Dosage Forms: This is the largest segment, encompassing tablets, capsules, and pills. It caters to a wide range of medications and offers ease of administration for patients.
• Injectable Products: These sterile dosage forms include solutions, suspensions, and emulsions delivered via injection. They are used for medications requiring rapid or targeted delivery.
• Active Pharmaceutical Ingredients (APIs): APIs are the core components of a drug that produce the intended therapeutic effect. CMOs can manufacture bulk or finished APIs for pharmaceutical companies.
Segmentation by Application:
• Large Enterprises: Major pharmaceutical companies often outsource manufacturing activities like large-scale production, complex formulations, or specific dosage forms. This allows them to focus on drug discovery, clinical trials, and marketing.
• Small and Medium Enterprises (SMEs): Smaller companies may lack the resources or infrastructure for in-house manufacturing. CMOs provide them with a cost-effective solution to produce their drugs and bring them to market.
Regional Analysis
• North America (Leader): Holds the top spot (over 40% share) due to:
o Established pharmaceutical and biotech companies.
o Stringent regulations requiring specialized expertise in CMOs.
o High R&D spending focused on innovation.
• Asia Pacific (Fast-Growing): This region experiences significant growth with:
o Lower manufacturing costs compared to North America and Europe.
o Rising government support for R&D and domestic pharma industries (China, India).
o Aging population driving demand for new drugs.
• Europe (Quality Focus): A mature market known for:
o Strong presence of global CMO companies with advanced capabilities.
o Emphasis on high-quality manufacturing and strict regulatory compliance.
o Potential limitations due to complex regulations and high labor costs.
• Emerging Players (Latin America, Middle East & Africa): These regions show promise with:
o Growing economies and rising healthcare expenditure.
o Untapped potential for CMO services.
o Need for affordable drug access, potentially favoring local manufacturing.
Key Developments
• Facility Expansion in Asia: WuXi AppTec, a major Chinese CMO, announced a $500 million expansion of its manufacturing facility in Massachusetts, USA in April 2024. This highlights the growing demand for CMO services from established players in North America.
• Focus on Gene Therapy: Lonza, a leading Swiss CMO, partnered with a biotech company in Europe in February 2024 to develop and manufacture a novel gene therapy treatment for a rare disease. This signifies the increasing involvement of CMOs in innovative areas of pharmaceuticals.
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Contract Pharmaceutical Manufacturing Market Size 2019-2030
2.1.2 Contract Pharmaceutical Manufacturing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Contract Pharmaceutical Manufacturing Segment by Type
2.2.1 Oral
2.2.2 Injectable
2.2.3 API
2.2.4 Other
2.3 Contract Pharmaceutical Manufacturing Market Size by Type
2.3.1 Contract Pharmaceutical Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Contract Pharmaceutical Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Contract Pharmaceutical Manufacturing Segment by Application
2.4.1 Large Enterprise
2.4.2 Small Medium Enterprise
2.5 Contract Pharmaceutical Manufacturing Market Size by Application
2.5.1 Contract Pharmaceutical Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Contract Pharmaceutical Manufacturing Market Size Market Share by Application (2019-2024)
3 Contract Pharmaceutical Manufacturing Market Size by Player
3.1 Contract Pharmaceutical Manufacturing Market Size Market Share by Players
3.1.1 Global Contract Pharmaceutical Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Contract Pharmaceutical Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Contract Pharmaceutical Manufacturing by Regions
4.1 Contract Pharmaceutical Manufacturing Market Size by Regions (2019-2024)
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More